TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$1.99
-0.01 (-0.50%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,961.8% upside
Low Target $36.60
Average Target $41.03
High Target $68.97
Current Price $1.99
Current
$1.99
Target
$41.03
$36.60 $41.03 avg $68.97
Scenario Analysis
Bear Case
$36.60
1,739.2%
Low target
Base Case
$41.03
+1,961.8%
Avg target
Bull Case
$68.97
+3,365.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.59
-56.6% from high
52-Week Low
$1.67
+19.2% from low
Target vs 52W High
$41.03
+793.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.2%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.8%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%